Cargando…
Treatment and Outcome of Metastatic Renal Cell Carcinoma With Sarcomatoid Differentiation: A Single-Center, Real-World Analysis of Retrospective Data
Background: Sarcomatoid differentiation/histology of renal cell carcinoma (sRCC) in patients with metastatic renal cell carcinoma (mRCC) is still underresearched in current therapy regimes. We aimed to evaluate the impact of sRCC on outcomes in patients with mRCC treated with tyrosine kinase inhibit...
Autores principales: | Janisch, Florian, Kienapfel, Christina, Fühner, Constantin, Klotzbücher, Thomas, Marks, Phillip, Hillemacher, Tobias, Meyer, Christian P., Iwata, Takehiro, Parizi, Mehdi Kardoust, Sauter, Guido, Fisch, Margit, Shariat, Shahrokh F., Dahlem, Roland, Rink, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636828/ https://www.ncbi.nlm.nih.gov/pubmed/34869564 http://dx.doi.org/10.3389/fsurg.2021.763271 |
Ejemplares similares
-
Predictive value of De Ritis ratio in metastatic renal cell carcinoma treated with tyrosine-kinase inhibitors
por: Janisch, Florian, et al.
Publicado: (2021) -
Do Younger Patients with Muscle-Invasive Bladder Cancer have Better Outcomes?
por: Janisch, Florian, et al.
Publicado: (2019) -
Focal Neuroendocrine Differentiation of Conventional Prostate Adenocarcinoma as a Prognostic Factor after Radical Prostatectomy: A Systematic Review and Meta-Analysis
por: Kardoust Parizi, Mehdi, et al.
Publicado: (2019) -
Female with bladder cancer: what and why is there a difference?
por: Marks, Phillip, et al.
Publicado: (2016) -
Prognostic value of T1 substaging on oncological outcomes in patients with non-muscle-invasive bladder urothelial carcinoma: a systematic literature review and meta-analysis
por: Kardoust Parizi, Mehdi, et al.
Publicado: (2019)